Jurnal Kefarmasian AKFARINDO/JOFAR is published by Akademi Farmasi Indonesia Yogyakarta, Indonesia (ISSN: 2528-7257 E-ISSN: 2528-7265). JOFAR was established in 2016 and published twice a year (March and September) in both of print and online version. JOFAR is an open access journal of pharmacy. Articles submitted in JOFAR are double-blind peer reviewed. The Articles related to issues in the field of Pharmacy, should be original, unpublished, and not under review for possible publications in other journals. The article will be reviewed by a team of journal editors.

The journal includes various fields of pharmaceuticals sciences such as: Pharmacology and Toxicology, Pharmacokinetics, Community and Clinical Pharmacy, Pharmaceutical Chemistry, Pharmaceutical Biology, Pharmaceutics, Pharmaceutical Technology, Biopharmaceutics, Pharmaceutical Microbiology and Biotechnology, Alternative medicines.

Manuscripts should be submitted online. Further inquiries could be directed to the secretariat of the JOFAR at jofar@afi.ac.id.

===========================================================================

Announcements

[NEWS] Introduction of Article Publication Charge (APC)

2025-05-20

Dear

Authors and Contributors,

We sincerely appreciate your continued support and contributions to JURNAL KEFARMASIAN AKFARINDO.

Starting with the publication of Volume 10 Number 2 September 2025, JURNAL KEFARMASIAN AKFARINDO will be implementing an Article Publication Charge (APC) of IDR 300,000 for each manuscript accepted for publication. This charge will only apply to manuscripts that have successfully undergone the peer review process and have been accepted for publication in our journal as per Volume 10 No. 2, Year 2025 onward.

For further information, please contact Editorial Assistant at jofar@afi.ac.id.

Thank you for your cooperation as we continue to strive for excellence in scholarly publishing.

Read more about [NEWS] Introduction of Article Publication Charge (APC)

Current Issue

Vol 10 No 1 (2025)
Published: 2025-03-21

Article

View All Issues